Glucagon Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

 According to the report published by Facts & Factors, the global Glucagon Market size was worth around USD 470 million in 2019 and is predicted to grow around USD 700 million by 2026 with a compound annual growth rate (CAGR) of roughly 5.8% between 2020 and 2026. The report analyzes the global Glucagon Market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Glucagon Market.

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Glucagon industry. The report analyzes and declares the historical and current trends analysis of the Glucagonindustry and subsequently recommends the projected trends anticipated to be observed in the Glucagon market during the upcoming years.

The Glucagon market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entireGlucagon market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.

Key Insights from Primary Research

• As per our primary respondents, the Glucagon market is set to grow annually at a rate of around 5.8%.
• It was established through primary research that the Glucagonmarket was valued at around USD 470million in 2019.
• After secondary research, we performed face to face interviews to validate our data. The insights interviewee’s declared that Inject Glucagon is the most used product for the global Glucagon market.
• On the basis of the industry, general use dominated the global Glucagonmarket in 2019. It accounted for around 43% share of the total market in 2019.
• The Inject Glucagon segment, on the basis of industry segmentation, was the leading revenue-generating category accounting for around 59% share, in 2019.

Key Recommendations from Analysts

• Based on the exhaustive secondary research done by our team, the Inject Glucagon is anticipated to become the most demanding product in the upcoming years, owing to the growing demand for Glucagonfrom the pharmaceutical industry for various end-use applications.
• As per our analysts, North America recorded the highest market share of more than 39% by 2026, and the market is expected to bolster in this region, resulting in creating lucrative opportunities for new players.
• Growing at a CAGR around 5.8%, the Glucagonmarket provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified Inject Glucagon and general use categories as the leading investment pockets for the Glucagonmarket in terms of product and industry segmentation respectively.
• Our analysts recommend the emerging players to focus on Inject Glucagon owing to the substantial growth of the pharmaceutical industry, especially in APAC and Middle-eastern regions and the presence of a humongous population in this region.

Market Attractiveness – By Industry

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the Glucagonindustry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the Glucagon industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Glucagon market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the Glucagon industry. The Glucagon market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the Glucagon sector. Key strategic developments in the Glucagon market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the Glucagon market are appropriately highlighted in the report.

Glucagon is a pancreatic enzyme that rapidly increases blood glucose levels in the body. Glucagon is also used in patients as a medicine to treat low blood sugar levels. Demand in Glucagon is expected to increase in the forecast period. Technological innovations increased awareness of glucagon and diabetes and increased global acceptance of glucagon are some of the factors driving the market growth. In addition, the Government plans to strengthen its life science initiative for the global glucagon industry in the future. Moreover, the growing growth of the pharmaceutical industry, combined with price competition, would give the global glucagon industry lucrative opportunities.

The Glucagon market research report delivers an acute valuation and taxonomy of the Glucagon industry by practically splitting the market on the basis of different types, applications, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the Glucagon industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the Glucagon industry is provided for the leading economies of the world.

The Glucagon market is segmented based on Product and Industry.  On the basis of product segmentation, the market is classified into Inject Glucagon, Nasal Glucagon, and Others. In terms of industry segmentation, the market is bifurcated into Emergency Kits, General Use, Diagnostic & Motility, and Others.

Report Scope

Competitive Players

Some of the essential players operating in the Glucagon market, but not restricted to include :

• Novo Nordisk
• Eli Lilly
• Fresenius Kabi AG
• Torrent Laboratory Inc.
• Taj Pharmaceuticals Ltd.
• Xeris Pharmaceuticals Inc.
• UNITED BIOTECH (P) LTD. 
• USV Private Limited

The taxonomy of the Glucagon Market by its scope and segmentation is as follows:

By ProductSegmentation Analysis(Customizable)

• Inject Glucagon
• Nasal Glucagon
• Others

By Application Segmentation Analysis(Customizable)

• Emergency Kits
• General Use
• Diagnostic & Motility
• Others

Regional Segmentation Analysis(Customizable)

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa